Health
Pfizer Goes It Alone to Expand Vaccine Business Beyond Covid-19 Pandemic – The Wall Street Journal
CEO Albert Bourla says company will use gene-based technology learned by working with Germany’s BioNTech to tackle other diseases
Pfizer Inc. aims to expand its vaccine business by becoming a leader in the new gene-based technology behind its successful Covid-19 shots.
Pfizer will develop new shots using the technology, called mRNA, to target other viruses and pathogens beyond the coronavirus, Chief Executive Albert Bourla said in an interview. He said the companys scientists and engineers gained a decades worth of experience in the past year working on the Covid-19 vaccine with Germanys BioNTech SE , and is ready to pursue…
-
Business18 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General16 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Business23 hours agoThis artificial intelligence (AI) stock will be the Nvidia of quantum computing by 2035
-
Noosa News18 hours agoLung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success